GR3026432T3 - Use of N,N'-bis 3-(ethylamino)propyl -1,7-heptanediamine and a cytotoxic agent - Google Patents

Use of N,N'-bis 3-(ethylamino)propyl -1,7-heptanediamine and a cytotoxic agent

Info

Publication number: GR3026432T3
Authority: GR; Greece
Prior art keywords: antineoplastic; heptanediamine; ethylamino; propyl; bis
Prior art date: 1990-12-13

Application number

GR980400622T

Other languages

English (en)

Inventor

Nellikunja J Prakash

Terry L Bowlin

Original Assignee

Merrell Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-13

Filing date

1998-03-20

Publication date

1998-06-30

1998-03-20 Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc

1998-06-30 Publication of GR3026432T3 publication Critical patent/GR3026432T3/el

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GR980400622T 1990-12-13 1998-03-20 Use of N,N'-bis 3-(ethylamino)propyl -1,7-heptanediamine and a cytotoxic agent GR3026432T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US62681490A	1990-12-13	1990-12-13

Publications (1)

Publication Number	Publication Date
GR3026432T3 true GR3026432T3 (en)	1998-06-30

Family

ID=24511975

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR980400622T GR3026432T3 (en)	1990-12-13	1998-03-20	Use of N,N'-bis 3-(ethylamino)propyl -1,7-heptanediamine and a cytotoxic agent

Country Status (11)

Country	Link
EP (1)	EP0490380B1 (el)
JP (1)	JPH04275233A (el)
KR (1)	KR100195423B1 (el)
AT (1)	ATE163264T1 (el)
AU (1)	AU648846B2 (el)
DE (1)	DE69128926T2 (el)
DK (1)	DK0490380T3 (el)
ES (1)	ES2113870T3 (el)
GR (1)	GR3026432T3 (el)
IE (1)	IE914331A1 (el)
ZA (1)	ZA919695B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0819432B1 (en) *	1996-01-31	2004-03-24	Japan Science and Technology Corporation	Antitumor agents comprising as the principal agent compounds containing silicon and nitrogen
US6274561B1 (en)	1997-01-29	2001-08-14	Japan Science & Technology Corp.	Antitumor agents comprising as the principal compounds containing silicon and nitrogen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ223340A (en) *	1987-02-03	1991-03-26	Merrell Dow Pharma	Polyamine derivatives and pharmaceutical compositions
EP0378146B1 (en) *	1989-01-10	1995-03-29	Merrell Pharmaceuticals Inc.	Polyamine derivatives as antineoplastic agents
ZA903804B (en) *	1989-05-23	1991-03-27	Merrell Dow Pharma	A method of potentiating cell-mediated immunity utilizing polyamine derivatives

1991
- 1991-12-09 AU AU88907/91A patent/AU648846B2/en not_active Ceased
- 1991-12-09 ZA ZA919695A patent/ZA919695B/xx unknown
- 1991-12-12 AT AT91121354T patent/ATE163264T1/de not_active IP Right Cessation
- 1991-12-12 ES ES91121354T patent/ES2113870T3/es not_active Expired - Lifetime
- 1991-12-12 EP EP91121354A patent/EP0490380B1/en not_active Expired - Lifetime
- 1991-12-12 IE IE433191A patent/IE914331A1/en not_active Application Discontinuation
- 1991-12-12 DE DE69128926T patent/DE69128926T2/de not_active Expired - Fee Related
- 1991-12-12 DK DK91121354T patent/DK0490380T3/da active
- 1991-12-12 KR KR1019910022757A patent/KR100195423B1/ko not_active Expired - Fee Related
- 1991-12-12 JP JP3350725A patent/JPH04275233A/ja active Pending
1998
- 1998-03-20 GR GR980400622T patent/GR3026432T3/el unknown

Also Published As

Publication number	Publication date
KR920011481A (ko)	1992-07-24
ATE163264T1 (de)	1998-03-15
AU648846B2 (en)	1994-05-05
AU8890791A (en)	1992-06-18
IE914331A1 (en)	1992-06-17
JPH04275233A (ja)	1992-09-30
KR100195423B1 (ko)	1999-06-15
ZA919695B (en)	1992-09-30
EP0490380A2 (en)	1992-06-17
DK0490380T3 (da)	1998-09-23
DE69128926T2 (de)	1998-06-04
DE69128926D1 (de)	1998-03-26
ES2113870T3 (es)	1998-05-16
EP0490380A3 (en)	1993-03-10
EP0490380B1 (en)	1998-02-18

Similar Documents

Publication	Publication Date	Title
HU0301601D0 (en)	2003-08-28	Bis(n-substituted)-staurosporine derivatives, their use and pharmaceutical composition containing thereof
IL96995A0 (en)	1992-03-29	Pharmaceutical compositions containing pimobendan and their preparation
NZ334124A (en)	2000-10-27	Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
PL307491A1 (en)	1995-09-04	Pharmaceutical agents for oral administration
GR3032382T3 (en)	2000-04-27	Taste-masked pharmaceutical compositions.
ZA918355B (en)	1992-07-29	Pharmaceutical compositions active in the therapy of neurological affections in aids patients,containing as an active principle at least one compound selected from the group consisting of s-adenosyl-l-methionine salt,5-methyl-tetrahydrofolic acid,5-formyltetrahydrofolic acid
PH30083A (en)	1996-12-27	Treatment of lower urinary tract disorders
IT1222395B (it)	1990-09-05	Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare
DE69014666D1 (de)	1995-01-19	Abgabe von cytotoxischen Mitteln.
DK0583026T3 (el)	1997-02-24
CA2033249A1 (en)	1991-07-05	Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures
GR3026432T3 (en)	1998-06-30	Use of N,N'-bis 3-(ethylamino)propyl -1,7-heptanediamine and a cytotoxic agent
DK0458589T3 (da)	1995-04-03	Behandling af okulær hypertension med en okulær synergistisk kombination
SE8900875L (sv)	1989-12-15	Osteoporosbehandling
ATE28566T1 (de)	1987-08-15	Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin.
EP0454429A3 (en)	1992-07-15	Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
ZA925852B (en)	1993-03-05	(-) and (+) 10-(1-azabicyclo(2.2.2.)oct-3-yl-methyl)-10 h-phenothiazine quaternary ammonium derivatives, pharmaceutical compositions containing them and process for their preparation.
FR2699920B1 (fr)	1995-02-10	Dérivés d'imidazo [2,1-b] benzothiazole-3-acétamide, leur préparation et leur application en thérapeutique.
SE8802323D0 (sv)	1988-06-21	8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
IT1242026B (it)	1994-02-02	Composizione farmaceutica contenente un complesso ferro-schizokinene per il trattamento dell'anemia ferropenica.
FR2717814B1 (fr)	1996-04-26	Dérivés de 1,2,4-triazolo(4,3-a)pyrazine-4-one, leur préparation et les médicaments les contenant.
FR2710062B1 (fr)	1995-12-01	Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant.
AU3934289A (en)	1990-02-08	Radioiodine benzodiazepine derivatives
EP0311467A3 (en)	1990-12-12	Use of pyrroloû3,2,1-hi¨indole derivatives in the manufacture of a medicament for the treatment of diabetes
ATE10095T1 (de)	1984-11-15	10-substituierte 5-cyanmethylen-10,11-dihydrodibenzo-(a,d)-cycloheptene, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.